Is Blind Pancreaticoduodenectomy Justified for Patients with Ampullary Neoplasms?
Overview
Affiliations
Background: Many specialists justify pancreaticoduodenectomy (PD) for pancreatic head neoplasms with suspected but unproven malignance (blind-PD). Our aim in this study was to determine whether blind-PD is also justified for ampullary neoplasms.
Methods: We retrospectively reviewed the records of all patients with presumed resectable ampullary neoplasms treated at the National Taiwan University Hospital from 1998 to 2008.
Results: Of the 84 patients without a preoperative tissue diagnosis of malignance, 64 had blind-PD and 20 had ampullectomy (AMP) with intraoperative frozen section. Patients with jaundice, gastrointestinal bleeding, imaging findings showing tumor invasion, and larger tumor size were significantly more frequently treated by blind-PD. Final pathological diagnosis was benign in ten of 64 blind-PD-treated patients.
Conclusions: Our data support a selective use of blind-PD because (1) a significant portion (65%) of benign ampullary neoplasms can be safely and effectively treated by AMP, (2) blind-PD does not treat ampullary cancer at earlier stage, and (3) blind-PD is associated with significantly more complications and significantly longer hospital stay than AMP. However, blind-PD is strongly recommended for patients with large ampullary neoplasms (>3 cm in diameter), with jaundice, or with malignant endoscopic appearance.
Wang W, Wang J, Yang C, Wang X, Zhang S, Wang J Eur J Med Res. 2024; 29(1):560.
PMID: 39587662 PMC: 11590497. DOI: 10.1186/s40001-024-02144-4.
Ampulla of Vater carcinoma: Molecular landscape and clinical implications.
Pea A, Riva G, Bernasconi R, Sereni E, Lawlor R, Scarpa A World J Gastrointest Oncol. 2018; 10(11):370-380.
PMID: 30487949 PMC: 6247104. DOI: 10.4251/wjgo.v10.i11.370.
Extraduodenal papillectomy: a feasible alternative method of total papillectomy.
Sata N, Koizumi M, Kaneda Y, Ishiguro Y, Kurogochi A, Endo K J Gastrointest Surg. 2013; 18(4):858-64.
PMID: 24347314 DOI: 10.1007/s11605-013-2430-z.
Review of the investigation and surgical management of resectable ampullary adenocarcinoma.
Askew J, Connor S HPB (Oxford). 2013; 15(11):829-38.
PMID: 23458317 PMC: 4503279. DOI: 10.1111/hpb.12038.
Roberts K, McCulloch N, Sutcliffe R, Isaac J, Muiesan P, Bramhall S HPB (Oxford). 2012; 15(1):18-23.
PMID: 23216775 PMC: 3533708. DOI: 10.1111/j.1477-2574.2012.00542.x.